VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 141 filers reported holding VIKING THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,491 | -11.2% | 225 | +30.1% | 0.00% | – |
| Q2 2023 | $2,804 | -2.6% | 173 | 0.0% | 0.00% | – |
| Q1 2023 | $2,880 | -91.8% | 173 | -97.7% | 0.00% | -100.0% |
| Q4 2021 | $35,000 | +775.0% | 7,500 | +1062.8% | 0.01% | +400.0% |
| Q3 2021 | $4,000 | 0.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -20.0% | 645 | -20.3% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 809 | +25.4% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -20.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +66.7% | 645 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -40.0% | 645 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $5,000 | +25.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $4,000 | -69.2% | 645 | -53.9% | 0.00% | -60.0% |
| Q1 2019 | $13,000 | -63.9% | 1,400 | -70.8% | 0.01% | -72.2% |
| Q4 2018 | $36,000 | – | 4,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |